• ̍̍ CSE: BRAX
  • ̍̍ OTC: BRAXF
  • ̍̍ FWB: 4960



Vancouver, British Columbia / March 4, 2020 – Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM), a wellness company specializing in the formulation and distribution of a suite of medicinal mushroom-infused products, began trading on the Canadian Securities Exchange (the “CSE”) on March 2, 2020, quoted under the ticker symbol “SHRM”.

In February 2020, the Company successfully completed an Initial Public Offering (the “IPO”) via lead agent PI Financial Corp. Champignon will also look to secure a listing on the Frankfurt Stock Exchange and quotation on the OTC Marketplace in the US as soon as practicable. Champignon’s anticipated tri-listing will afford its current shareholders pre-eminent liquidity, all while contributing to a genuine global presence through improved accessibility for international capital flows.

Champignon will now aggressively pursue its mission of researching and distributing premium medicinal mushrooms-infused products, which target high-margin markets, as well as consumers interested in the health and wellness benefits associated with mushrooms.

During the balance of Q1 2020, the Company will continue to accelerate the market growth of its mushroom-infused portfolio, as well as optimize its e-commerce and fulfillment infrastructure.

“We are dedicated to transforming the health and wellness industry via the infusion of our proprietary blend of medicinal mushrooms,” stated Gareth Birdsall, Chief Executive Officer of Champignon. “We’ve been assembling a dedicated roster of mycologists and health and wellness professionals to formulate several distinctive lines of premium fungi extracts. The overall product portfolio is tailored for conscious consumers looking to support mental health and bolster cognitive performance through medicinal mushroom based products. We believe that we are only scratching the surface when it comes to unlocking the benefits hidden in medicinal mushrooms.”

With dedicated global fulfillment infrastructure in place, the Company is positioned to capitalize on the burgeoning craft mushroom market, affording current and prospective customers the ability to procure a selection of mushroom-infused products.


Champignon is proceeding with the formation of a special advisory committee to evaluate the potential positive effects its medicinal mushroom formulations could have on individuals suffering from mental health disorders such as depression, PTSD (post traumatic stress disorder) as well as substance and alcohol use disorders. The Company will appoint advisory board members who are qualified and experienced in areas such as medicine, psychology, mycology, and pharmacology to assist with this research initiative.

About Champignon Brands Inc.

Champignon Brands is intent on being a global, vertically integrated producer of artisanal medicinal mushrooms and associated products. The Champignon team is focused on enhancing the health and wellness of millions of consumers who can benefit from its premium suite of organic, sustainable and non-GMO mushroom formulations.


Gareth Birdsall
CEO & Director
T: +1 (778) 809-6664

For Champignon Brands French inquiries:

Remy Scalabrini, Maricom Inc.
E: [email protected]
T: +1 (888) 585-MARI

The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the business plans for Champignon Brands described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which are available at www.sedar.com.